Patents by Inventor Nicolas Luc SABOURAULT

Nicolas Luc SABOURAULT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20230406857
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: April 25, 2023
    Publication date: December 21, 2023
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH, Piet WIGERINCK
  • Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
    Patent number: 11667633
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: June 6, 2023
    Assignee: GALAPAGOS NV
    Inventors: Nicolas Luc Sabourault, Piet Wigerinck
  • NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20210269435
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: January 8, 2021
    Publication date: September 2, 2021
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH, Piet WIGERINCK
  • Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
    Patent number: 10919890
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: February 16, 2021
    Assignee: GALAPAGOS NV
    Inventors: Nicolas Luc Sabourault, Piet Wigernick
  • NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20200244651
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: September 30, 2019
    Publication date: July 30, 2020
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH
  • Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
    Patent number: 10708263
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: July 7, 2020
    Assignee: GALAPAGOS NV
    Inventors: Piet Wigerinck, Nicolas Luc Sabourault
  • Pharmaceutical compositions for the treatment of inflammatory disorders
    Patent number: 10493158
    Abstract: The present invention discloses pharmaceutical compositions comprising: a compound according to Formula I: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: December 3, 2019
    Assignee: GALAPAGOS NV
    Inventors: Marc Maurice Germain De Weer, Sara Bertha Camiel Vrielynck, Nicolas Luc Sabourault, Jan Peter Moeschwitzer
  • NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20180007043
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: July 10, 2017
    Publication date: January 4, 2018
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH
  • NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20160376269
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: July 1, 2016
    Publication date: December 29, 2016
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH
  • Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
    Patent number: 9382247
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: July 5, 2016
    Assignee: GALAPAGOS NV
    Inventors: Nicolas Luc Sabourault, Carla De Faveri, Ahmad Sheikh
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20150224199
    Abstract: The present invention discloses pharmaceutical compositions comprising: a compound according to Formula I: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 13, 2015
    Inventors: Marc Maurice Germain DE WEER, Sara Bertha Camiel VRIELYNCK, Nicolas Luc SABOURAULT, Jan Peter MOESCHWITZER
  • NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20150225398
    Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 13, 2015
    Inventors: Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH